Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Production & Manufacturing
OTC
Return to: PBR Home | Production & Manufacturing | OTC

OTC

SAFC introduces new protein quality supplement to increase N-linked Glycosylation Sigma-Aldrich has announced that SAFC Commercial, its custom manufacturing services business unit, has introduced a new protein quality supplement called EX-CELL Glycosylation Adjust (Gal+).
Production & Manufacturing > OTC > News
Plandai secures approval in Uruguay to grow cannabis for medical research Plandaí Biotechnology, a developer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, has announced that Uruguay's Ministry of Public Health has approved an academic collaboration between Plandaí and the Group of Medicinal Chemistry from the School of Science at the University of the Republic in Montevideo, Uruguay.
Production & Manufacturing > OTC > News Gryphon Investors takes over majority stake in CB Fleet Gryphon Investors, a San Francisco-based middle market private equity firm, has acquired a majority stake in C. B. Fleet Company (“Fleet Laboratories” or “the Company”).
Production & Manufacturing > OTC > News
See more OTC news

Latest OTC News and Insight

View all OTC news or find news targeted to your interests
US Health Coalition issues important medicine safety tips for cold and flu sufferers
The Acetaminophen Awareness Coalition (AAC) is kicking off its annual "Double Check; Don't Double Up" campaign, reminding consumers to double check their medicine labels to avoid doubling up on medicines with acetaminophen when treating cold and flu symptoms.
Production & Manufacturing > OTC > News
PlasmaTech, Norgine sign license deal to commercialize MuGard in Australia and New Zealand
By PBR Staff Writer
PlasmaTech Biopharmaceuticals has entered into an exclusive license agreement with European pharmaceutical firm Norgine to commercialize MuGard, an oral mucoadhesive, in Australia and New Zealand.
Production & Manufacturing > OTC > News
Alternaturals plans for new manufacturing facility to meet expected revenue growth
Alternaturals has announced intentions of establishing a company owned manufacturing facility to fulfill the expected orders that will inevitably result from their affiliate marketing program and potential business contracts with large retailers.
Production & Manufacturing > OTC > News
Contract Packaging Resources recalls Assured brand Naproxen Sodium tablets
By PBR Staff Writer
US-based drug repackaging firm Contract Packaging Resources has recalled 11,640 boxes of over-the-counter (OTC) pain reliever Assured brand Naproxen Sodium tablets 220mg due to packaging mix-up.
Production & Manufacturing > OTC > News
CHPA statement on pediatrics study reporting medication errors in children
The Consumer Healthcare Products Association (CHPA) issued the following statement in response to a study published today in Pediatrics. The study found that from 2002 to 2012 cough and cold medication errors decreased significantly in children under 6 years old, but the number of other medication errors rose to an average of 63,358 per year.
Production & Manufacturing > OTC > News
Therapix Biosciences signs non-binding agreement to acquire Dekel Pharmaceuticals
Therapix Bio announces that it recently entered into a Term Sheet for the acquisition of Dekel Pharmaceuticals, a privately-held company engaged in the research and development of drug therapies based on synthetic cannabinoid substances.
Production & Manufacturing > OTC > News
Cerus submits compassionate use IDE supplement for INTERCEPT Blood System treatment of ebola convalescent plasma
Cerus announced submission of a clinical protocol to the U.S. Food and Drug Administration (FDA) to make the INTERCEPT Blood System for plasma available under a Compassionate Use Investigational Device Exemption (IDE) for treatment of convalescent plasma collected from Ebola disease survivors for passive immune therapy.
Production & Manufacturing > OTC > News
Actavis seeks FDA approval to market Methylphenidate Hydrochloride 5mg/mL
By PBR Staff Writer
Irish pharmaceutical firm Actavis has submitted an abbreviated new drug application (ANDA) to the US Food and Drug Administration (FDA) seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5mg/mL.
Production & Manufacturing > OTC > News
Noven files patent infringement lawsuit against Actavis
Noven Pharmaceuticals has announced that it has filed a lawsuit in the U.S. District Court of New Jersey against Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Andrx Corp., and Actavis, Inc. for infringement of certain Noven patents.
Production & Manufacturing > OTC > News
Axxess Pharma launches new TapouT Turbo Blend protein powder
By PBR Staff Writer
Axxess Pharma through its subsidiary AllStar Health Brands has launched a new TapouT Turbo Blend Protein Powder.
Production & Manufacturing > OTC > News
View all OTC news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250